CV Sciences, Inc. — Operating Income by Fiscal Year
14 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/55710431-5c9d-47b1-b212-1915781f2b77/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-470.0k | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-126598 |
| FY 2024 | $-2.2M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-046180 |
| FY 2023 | $3.4M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-038736 |
| FY 2022 | $-6.8M | 2022-01-01 – 2022-12-31 | evidence 0001510964-23-000016 |
| FY 2021 | $-18.4M | 2021-01-01 – 2021-12-31 | evidence 0001510964-22-000033 |
| FY 2020 | $-22.6M | 2020-01-01 – 2020-12-31 | evidence 0001510964-21-000012 |
| FY 2019 | $-17.2M | 2019-01-01 – 2019-12-31 | evidence 0001510964-20-000026 |
| FY 2018 | $10.2M | 2018-01-01 – 2018-12-31 | evidence 0001510964-19-000007 |
| FY 2017 | $-4.9M | 2017-01-01 – 2017-12-31 | evidence 0001510964-19-000007 |
| FY 2016 | $-13.1M | 2016-01-01 – 2016-12-31 | evidence 0001683168-17-000725 |
| FY 2015 | $-11.2M | 2015-01-01 – 2015-12-31 | evidence 0001019687-16-005892 |
| FY 2014 | $-8.6M | 2014-01-01 – 2014-12-31 | evidence 0001019687-15-001189 |
| FY 2013 | $-1.6M | 2013-01-01 – 2013-12-31 | evidence 0001019687-14-001057 |
| FY 2012 | $-43.0k | 2012-01-01 – 2012-12-31 | evidence 0001019687-14-001057 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).